Vivacitas Oncology Inc.
Scott VanderMeer is a Managing Partner and co-founder of International Infusion Holdings, International Infusion Advisors, and Infusion 51a LP. Scott is also the CEO, CFO, Co-founder, and Director of Vivacitas Oncology Inc., a clinical stage biopharmaceutical company. In addition, Scott served as the CFO of Theralink Technologies, Inc., where Scott focused on restructuring the company and increasing revenue. Scott has a Bachelor's Degree in Marketing, Business, Management, Marketing, and Related Support Services, and a Master of Business Administration (MBA) with a concentration in Real Estate from the University of Illinois Chicago.
This person is not in any teams
This person is not in any offices
Vivacitas Oncology Inc.
Vivacitas Oncology is a biopharmaceutical company with a focus on combating cancers resistant to current treatment modalities. The company was co-founded in 2015 by Dr. Rubinfeld with an eye toward re-designing well-known chemotherapies that have already been demonstrated to have beneficial effects, but which may also possess potency, toxicity,stability, and/or pharmacokinetic issues that limit their use.